Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents

被引:18
|
作者
Kim, Jung-Sun [2 ]
Lee, Seung-Yul [2 ]
Lee, Jung Myung [2 ]
Yoon, Young Won [1 ]
Ahn, Chul-Min [2 ]
Kim, Myung-Hyun [1 ]
Min, Pil-Ki [1 ]
Ko, Young-Guk [2 ]
Hong, Bum-Kee [1 ]
Choi, Donghoon [2 ]
Kwon, Hyuck Moon [1 ]
Jang, Yangsoo [2 ]
Shim, Won-Heum [2 ]
机构
[1] Yonsei Univ, Coll Med, Yong Dong Severance Hosp, Div Cardiol, Seoul 135720, South Korea
[2] Yonsei Univ, Coll Med, Yong Dong Severance Hosp, Div Cardiol,Yonsei Cardiovasc Ctr, Seoul 135720, South Korea
关键词
restenosis; sirolimus-eluting stent; stent fracture; CLINICAL IMPACT; IMPLANTATION; PREDICTORS; LESIONS;
D O I
10.1097/MCA.0b013e32830fd101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Several reports have suggested that stent fractures in sirolimus-eluting stents (SESs) might be related to in-stent restenosis (ISR). However, the role of stent strut fracture in ISR has not been clearly elucidated. Therefore, we investigated the association of the SES fracture and ISR. Methods From 2003 to 2006, SES implantations with follow-up coronary angiography (CAG) for 628 lesions in 557 patients were analyzed. We reviewed clinical and procedural factors that might affect SES fracture and ISR. The median time interval from stent implantation to follow-up CAG was 9 months (range: 2-30 months). Results ISR occurred in 38 patients (5.7%), and 21 stent fractures (3.3%) were identified by follow-up CAG. Fourteen cases occurred in the left anterior descending artery, and seven occurred in the right coronary artery. The binary ISR rate in the stent fracture group was higher compared with that of the nonfracture group (38.1% vs. 4.6%, P < 0.001). Predictors of ISR as estimated by multivariate analysis were a stent diameter less than 2.75 mm [odds ratio (OR)=2.76, P=0.012], a stent length over 28 mm (OR=3.30, P=0.024), and stent fracture (OR=11.03, P < 0.001) after controlling for the angiographic and clinical risk factors of ISR. Conclusion Stent fracture was an independent predictor of ISR and may be one of the crucial mechanisms of ISR after implantation of an SES. Coron Artery Dis 20:59-63 (c) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 50 条
  • [1] Treatment of coronary in-stent restenosis with sirolimus-eluting stents
    Urban, P
    Guagliumi, G
    Gershlick, A
    Lotan, C
    Sousa, E
    Wijns, W
    Seth, A
    EUROPEAN HEART JOURNAL, 2004, 25 : 671 - 671
  • [2] Late Restenosis of Sirolimus-eluting Stent in the Treatment of In-stent Restenosis of Sirolimus-eluting Stent
    Shibayama, Kentaro
    Kadota, Kazushige
    Tsujimoto, Yuki
    Saito, Naoki
    Miyamoto, Masakazu
    Otsuru, Suguru
    Okamoto, Yoji
    Imai, Masao
    Tasaka, Hiroshi
    Hasegawa, Daiji
    Shigemoto, Yoshikazu
    Habara, Seiji
    Tanaka, Hiroyuki
    Maruo, Takeshi
    Hirono, Akitoshi
    Nishibori, Yosiharu
    Hosogi, Shingo
    Fuku, Yasushi
    Oka, Naoki
    Katoh, Hurumi
    Yamamoto, Hiroyuki
    Fujii, Satoki
    Goto, Tsuyoshi
    Inoue, Katsumi
    Mitsudo, Kazuaki
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 161D - 161D
  • [3] In-stent restenosis after sirolimus-eluting stent implantation is related to coronary stent fracture
    Lee, S. Y.
    Kim, M. H.
    Ahn, C. M.
    Kim, J. S.
    Choi, D. H.
    Jang, Y. S.
    Chung, N. S.
    Min, P. K.
    Yoon, Y. W.
    Hong, B. K.
    CIRCULATION, 2007, 116 (16) : 467 - 468
  • [4] Sirolimus-eluting stent for treatment of in-stent restenosis
    Le Feuvre, C
    Montalescot, G
    Rosey, G
    Monsegu, J
    Ohanessian, A
    Spaulding, C
    Drobinski, G
    Metzger, JP
    EUROPEAN HEART JOURNAL, 2004, 25 : 316 - 316
  • [5] Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture
    Watanabe, Toru
    Tamura, Akira
    Miyamoto, Kumie
    Kadota, Junichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 (01) : E12 - E13
  • [6] Treatment of renal artery in-stent restenosis with sirolimus-eluting stents
    Kiernan, Thomas J.
    Yan, Bryan P.
    Eisenberg, Jonathan D.
    Ruggiero, Nicholas J.
    Gupta, Vishal
    Drachman, Douglas
    Schainfeld, Robert M.
    Jaff, Michael R.
    Rosenfield, Kenneth
    Garasic, Joseph
    VASCULAR MEDICINE, 2010, 15 (01) : 3 - 7
  • [7] Sirolimus-Eluting Stents: Safe and effective in the treatment of in-stent restenosis
    Neumann, FJ
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 66 (02) : 163 - 164
  • [8] Sirolimus-eluting stent implantation for unselected in-stent restenosis
    Cho, KH
    Jeong, YS
    Kim, SM
    Kim, DI
    Kim, DS
    Kim, KB
    Kim, KS
    Hur, SH
    Kim, YJ
    Park, JS
    Shim, BS
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (8A): : 44A - 44A
  • [9] Treatment of coronary in-stent restenosis using sirolimus-eluting stent in the real world
    Barragan, PT
    Commeau, P
    Roquebert, P
    Bouvier, JL
    Comet, B
    Macaluso, G
    CIRCULATION, 2003, 108 (17) : 408 - 408
  • [10] Sirolimus-eluting stents for treatment of in-stent restenosis -: Immediate and late results
    Medina, A
    de Lezo, JS
    Pan, M
    Delgado, A
    Segura, J
    Pavlovic, D
    Melián, F
    Romero, M
    Segura, F
    Hernández, E
    Ureña, I
    Herrador, J
    TEXAS HEART INSTITUTE JOURNAL, 2005, 32 (01): : 11 - 15